Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 240

Sort by

Sort Order Select

Journal Articles

Stable Neurocognitive Function with Improvement in Processing Speed Following Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan in Children and Adolescents with Sickle Cell Disease

Dilan A Patel, MD, Kemar V Prussien, Karina L Wilkerson, NP, MSN, Becky Armstrong, PhD, Leena Karnik, FRCPath, MRCP, Adetola A. Kassim, MDMS, Josu de la Fuente, FRCP, PhD FRCPath

Blood (2019) 134 (Supplement_1): 2277.

https://doi.org/10.1182/blood-2019-124769

Published: 2019

Journal Articles

Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Blood (2019) 134 (Supplement_1): 1321.

https://doi.org/10.1182/blood-2019-128568

Published: 2019

Journal Articles

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Norina Tanaka, MD PhD, Aya Watanabe, MD, Suguru Honda, MD, Mitsuko Kobayashi, Yan-Hua Wang, MD, Yuki Iizuka, MD, Michiko Ryuzaki, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Katsunori Ikari, MD PhD, Masayuki Shiseki, MD PhD, Masayoshi Harigai, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 5219.

https://doi.org/10.1182/blood-2019-127836

Published: 2019

Journal Articles

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Blood (2019) 134 (Supplement_1): 44.

https://doi.org/10.1182/blood-2019-124644

Published: 2019

Journal Articles

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

Vijaya R. Bhatt, MD, Valerie K Shostrom, Sarah A. Holstein, MD PhD, Zaid S. Al-Kadhimi, MD, Lori J. Maness, MD, Ann Berger, PhD APRN-CNS, AOCNS, FAAN, James O. Armitage, MD, Krishna Gundabolu, MBBS

Blood (2019) 134 (Supplement_1): 2155.

https://doi.org/10.1182/blood-2019-122679

Published: 2019

Journal Articles

Elevated Plasma sIL-2Rα Levels in Primary Myelofibrosis Play a Distinct Role on Disease Progression in JAK2V617F and Calr Mutants

Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Mara De Amici, Carlotta Abbà, MSc, Gianluca Viarengo, Laura Villani, Margherita Massa, Vittorio Rosti, MD

Blood (2019) 134 (Supplement_1): 1678.

https://doi.org/10.1182/blood-2019-125531

Published: 2019

Journal Articles

Plasma EDA Fibronectin in Primary Myelofibrosis Correlates with Bone Marrow Fibrosis and Predicts Splenomegaly

Alessandro Malara, PhD, Cristian Gruppi, PhD, Margherita Massa, Vittorio Rosti, MD, Giovanni Barosi, Alessandra Balduini, MD

Blood (2019) 134 (Supplement_1): 1688.

https://doi.org/10.1182/blood-2019-130735

Published: 2019

Journal Articles

The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants

Blood (2019) 134 (Supplement_1): 3021.

https://doi.org/10.1182/blood-2019-130907

Published: 2019

Journal Articles

Mantle CELL Lymphoma (MCL) in Elderly Patients (PTs): The Experience in Real-Life of Rete Ematologica Laziale Linfomi (RELLI)

Alessandro Alessandro Andriani, Gabriella Tomei, Cristiano Tesei, Ombretta Annibali, Cristina Andrizzi, Fiammetta Natalino, MD, Paola Anticoli Borza, Elisabetta Abruzzese, MD, Elena Maiolo, Alice Di Rocco, Luigi Petrucci, MD, Maria Cantonetti, Fioretta Palombi, Natalia Cenfra, MD, Luigi Rigacci, MD, Stefan Hohaus, MD, Maurizio Martelli, MD, N. Christina Cox, MD

Blood (2019) 134 (Supplement_1): 5257.

https://doi.org/10.1182/blood-2019-124696

Published: 2019

Journal Articles

Post Allograft Rituximab Responsive Cytopenia (RRC)

Samar Kulkarni, MD, John Murray, RGN, MSc, David Kaye, MSc, Michael Dennis, FRCPath, Anna Castleton, FRCPath, Mohd K Mamat, MRCP, James Cavet, Daniel Wiseman, FRCPath, Tim Somervaille, FRCPath, Sven Sommerfeld, MRCP, Richard Chasty, FRCPath, Adrian Bloor, FRCPath

Blood (2019) 134 (Supplement_1): 5645.

https://doi.org/10.1182/blood-2019-132214

Published: 2019

Journal Articles

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

Tania Aguado, MD, Antonio Olivas-Martinez, MD, Uvi Cancino-Ramos, MD, Diego Zúñiga, MD, Carmen Lome, MD, Silvia Rivas-Vera, MD, Myrna Candelaria, MD PharmD

Blood (2019) 134 (Supplement_1): 5813.

https://doi.org/10.1182/blood-2019-126231

Published: 2019

Journal Articles

A Novel Machine Learning Based in silico Pathogenicity Predictor for Missense Variants in a Hematological Setting

Stephan Hutter, PhD, Constance Baer, PhD, Wencke Walter, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 2090.

https://doi.org/10.1182/blood-2019-128488

Published: 2019

Journal Articles

FA Gene Carrier Status Predisposes to Myeloid Neoplasms and Bone Marrow Failure in Adults

Jibran Durrani, Hassan Awada, MD, Wenyi Shen, MD, Cassandra M Kerr, MS, Vera Adema, PhD, Sunisa Kongkiatkamon, Ashwin Kishtagari, MBBS, Samuel Li, Yasunobu Nagata, MD PhD, Sanghee Hong, MD, Aziz Nazha, MD, Bhumika J. Patel, MD, Yogenthiran Saunthararajah, MD, Hetty E. Carraway, MD MBA, Valeria Visconte, PhD, Seth J. Corey, MD, Mikkael A. Sekeres, MD MS, Thomas Laframboise, PhD, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 452.

https://doi.org/10.1182/blood-2019-130142

Published: 2019

Journal Articles

Genetic of Sporadic Hemophagocytic Lymphohistiocytosis

Coralie Bloch, MD PhD, Jean-Philippe Jais, MD PhD, Marine Gil, Marouane Boubaya, PhD, Felipe Suarez, MD PhD, Brigitte Bader-Meunier, MD, Nizar Malhaoui, MD PhD, Alain Fischer, MD PhD, Genevieve de Saint Basile, MD PhD, Olivier Hermine, MD PhD

Blood (2019) 134 (Supplement_1): 82.

https://doi.org/10.1182/blood-2019-129743

Published: 2019

Journal Articles

MCRN ¯ 003/MYX · 1: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma after 1-3 Prior Therapies

Christopher P. Venner, MD FRCPC, Richard Leblanc, MDFRCPC, Irwindeep Sandhu, MDFRCPC, Darrell J. White, MD, Andrew R Belch, MD, Donna E Reece, MD, Christine I Chen, MD, Sean Dolan, MD, Andrea Kew, MDFRCP(C), Marc Lalancette, MD FRCP, Martha L Louzada, MD, Arleigh McCurdy, MD BSc, Gail T. McDonald, Tony Reiman, MD, Laura Rodriguez, Lois E. Shepherd, Engin Gul, BSc, Bingshu E. Chen, Annette E Hay

Blood (2018) 132 (Supplement 1): 1984.

https://doi.org/10.1182/blood-2018-99-117824

Published: 2018

Journal Articles

Association between Treatment Facility Volume and Mortality of Patients with Hodgkin Lymphoma

Gaurav Goyal, MBBS, Shealeigh Funni, Jonathan Inselman, Urshila Durani, MD, Nilay Shah, PhD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 2257.

https://doi.org/10.1182/blood-2018-99-119775

Published: 2018

Journal Articles

Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States

Anuhya Kommalapati, MD, Sri Harsha Tella, MD, Ronald S. Go, MD, Gaurav Goyal, MBBS

Blood (2018) 132 (Supplement 1): 3031.

https://doi.org/10.1182/blood-2018-99-110137

Published: 2018

Journal Articles

Prognosis after Upfront Radiation Therapy in Plasma Cell Myeloma: Analysis of the National Cancer Data Base

Xavier Orcutt, BA, Peter Barth, MD, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 3230.

https://doi.org/10.1182/blood-2018-99-110108

Published: 2018

Journal Articles

Diagnosis-to-Treatment Interval As a Prognostic Factor in Aggressive T-Cell Lymphomas

Thomas A Ollila, MD, John L. Reagan, MD, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 2913.

https://doi.org/10.1182/blood-2018-99-110231

Published: 2018

Journal Articles

Role of Systemic High-Dose Methotrexate and Combined Approaches in the Management of Vitreoretinal Diffuse Large B-Cell Lymphoma: A Single Center Experience 1990-2018

Alessia Castellino, MD, Jose Pulido, PhD, Patrick Johnston, Kay M. Ristow, BS, Nabila Nora Bennani, MD, David J Inwards, MD, William R. Macon, MD, Ivana N Micallef, MD, Rebecca L King, MD, Diva Salomao, MD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Grzegorz Nowakowski, MD

Blood (2018) 132 (Supplement 1): 574.

https://doi.org/10.1182/blood-2018-99-113826

Published: 2018

NARROW

Stable Neurocognitive Function with Improvement in Processing Speed Following Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan in Children and Adolescents with Sickle Cell Disease

Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

Elevated Plasma sIL-2Rα Levels in Primary Myelofibrosis Play a Distinct Role on Disease Progression in JAK2V617F and Calr Mutants

Plasma EDA Fibronectin in Primary Myelofibrosis Correlates with Bone Marrow Fibrosis and Predicts Splenomegaly

The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants

Mantle CELL Lymphoma (MCL) in Elderly Patients (PTs): The Experience in Real-Life of Rete Ematologica Laziale Linfomi (RELLI)

Post Allograft Rituximab Responsive Cytopenia (RRC)

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

A Novel Machine Learning Based in silico Pathogenicity Predictor for Missense Variants in a Hematological Setting

FA Gene Carrier Status Predisposes to Myeloid Neoplasms and Bone Marrow Failure in Adults

Genetic of Sporadic Hemophagocytic Lymphohistiocytosis

MCRN ¯ 003/MYX · 1: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma after 1-3 Prior Therapies

Association between Treatment Facility Volume and Mortality of Patients with Hodgkin Lymphoma

Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States

Prognosis after Upfront Radiation Therapy in Plasma Cell Myeloma: Analysis of the National Cancer Data Base

Diagnosis-to-Treatment Interval As a Prognostic Factor in Aggressive T-Cell Lymphomas

Role of Systemic High-Dose Methotrexate and Combined Approaches in the Management of Vitreoretinal Diffuse Large B-Cell Lymphoma: A Single Center Experience 1990-2018

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only